The global Cannabis Use Disorder Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cannabis Use Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cannabis Use Disorder Treatment.

Report Scope

The Cannabis Use Disorder Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cannabis Use Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cannabis Use Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cannabis Use Disorder Treatment Market Report

Report Metric	Details
Report Name	Cannabis Use Disorder Treatment Market
CAGR	5%
Segment by Type	Tobacco/Nicotine and Vaping Alcohol Marijuana Synthetic Cannabinoids Others
Segment by Application	Hospitals and Clinics Rehabilitation Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Alkermes, BioCorRx, Cipla Limited, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Indivior, Mallinckrodt, Noramco, Orexo AB, Purdue Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cannabis Use Disorder Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cannabis Use Disorder Treatment Market report?

Ans: The main players in the Cannabis Use Disorder Treatment Market are AbbVie, Alkermes, BioCorRx, Cipla Limited, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Limited, Indivior, Mallinckrodt, Noramco, Orexo AB, Purdue Pharma

What are the Application segmentation covered in the Cannabis Use Disorder Treatment Market report?

Ans: The Applications covered in the Cannabis Use Disorder Treatment Market report are Hospitals and Clinics, Rehabilitation Centers, Others

What are the Type segmentation covered in the Cannabis Use Disorder Treatment Market report?

Ans: The Types covered in the Cannabis Use Disorder Treatment Market report are Tobacco/Nicotine and Vaping, Alcohol, Marijuana, Synthetic Cannabinoids, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cannabis Use Disorder Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Tobacco/Nicotine and Vaping

1.2.3 Alcohol

1.2.4 Marijuana

1.2.5 Synthetic Cannabinoids

1.2.6 Others

1.3 Market by Application

1.3.1 Global Cannabis Use Disorder Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals and Clinics

1.3.3 Rehabilitation Centers

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cannabis Use Disorder Treatment Market Perspective (2019-2030)

2.2 Cannabis Use Disorder Treatment Growth Trends by Region

2.2.1 Global Cannabis Use Disorder Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cannabis Use Disorder Treatment Historic Market Size by Region (2019-2024)

2.2.3 Cannabis Use Disorder Treatment Forecasted Market Size by Region (2025-2030)

2.3 Cannabis Use Disorder Treatment Market Dynamics

2.3.1 Cannabis Use Disorder Treatment Industry Trends

2.3.2 Cannabis Use Disorder Treatment Market Drivers

2.3.3 Cannabis Use Disorder Treatment Market Challenges

2.3.4 Cannabis Use Disorder Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cannabis Use Disorder Treatment Players by Revenue

3.1.1 Global Top Cannabis Use Disorder Treatment Players by Revenue (2019-2024)

3.1.2 Global Cannabis Use Disorder Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Cannabis Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cannabis Use Disorder Treatment Revenue

3.4 Global Cannabis Use Disorder Treatment Market Concentration Ratio

3.4.1 Global Cannabis Use Disorder Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cannabis Use Disorder Treatment Revenue in 2023

3.5 Cannabis Use Disorder Treatment Key Players Head office and Area Served

3.6 Key Players Cannabis Use Disorder Treatment Product Solution and Service

3.7 Date of Enter into Cannabis Use Disorder Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cannabis Use Disorder Treatment Breakdown Data by Type

4.1 Global Cannabis Use Disorder Treatment Historic Market Size by Type (2019-2024)

4.2 Global Cannabis Use Disorder Treatment Forecasted Market Size by Type (2025-2030)

5 Cannabis Use Disorder Treatment Breakdown Data by Application

5.1 Global Cannabis Use Disorder Treatment Historic Market Size by Application (2019-2024)

5.2 Global Cannabis Use Disorder Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cannabis Use Disorder Treatment Market Size (2019-2030)

6.2 North America Cannabis Use Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cannabis Use Disorder Treatment Market Size by Country (2019-2024)

6.4 North America Cannabis Use Disorder Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cannabis Use Disorder Treatment Market Size (2019-2030)

7.2 Europe Cannabis Use Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cannabis Use Disorder Treatment Market Size by Country (2019-2024)

7.4 Europe Cannabis Use Disorder Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cannabis Use Disorder Treatment Market Size (2019-2030)

8.2 Asia-Pacific Cannabis Use Disorder Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cannabis Use Disorder Treatment Market Size (2019-2030)

9.2 Latin America Cannabis Use Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cannabis Use Disorder Treatment Market Size by Country (2019-2024)

9.4 Latin America Cannabis Use Disorder Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cannabis Use Disorder Treatment Market Size (2019-2030)

10.2 Middle East & Africa Cannabis Use Disorder Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Detail

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Cannabis Use Disorder Treatment Introduction

11.1.4 AbbVie Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.1.5 AbbVie Recent Development

11.2 Alkermes

11.2.1 Alkermes Company Detail

11.2.2 Alkermes Business Overview

11.2.3 Alkermes Cannabis Use Disorder Treatment Introduction

11.2.4 Alkermes Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.2.5 Alkermes Recent Development

11.3 BioCorRx

11.3.1 BioCorRx Company Detail

11.3.2 BioCorRx Business Overview

11.3.3 BioCorRx Cannabis Use Disorder Treatment Introduction

11.3.4 BioCorRx Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.3.5 BioCorRx Recent Development

11.4 Cipla Limited

11.4.1 Cipla Limited Company Detail

11.4.2 Cipla Limited Business Overview

11.4.3 Cipla Limited Cannabis Use Disorder Treatment Introduction

11.4.4 Cipla Limited Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.4.5 Cipla Limited Recent Development

11.5 Dr. Reddy’s Laboratories

11.5.1 Dr. Reddy’s Laboratories Company Detail

11.5.2 Dr. Reddy’s Laboratories Business Overview

11.5.3 Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Introduction

11.5.4 Dr. Reddy’s Laboratories Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.5.5 Dr. Reddy’s Laboratories Recent Development

11.6 Glenmark Pharmaceuticals Limited

11.6.1 Glenmark Pharmaceuticals Limited Company Detail

11.6.2 Glenmark Pharmaceuticals Limited Business Overview

11.6.3 Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Introduction

11.6.4 Glenmark Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.6.5 Glenmark Pharmaceuticals Limited Recent Development

11.7 Intas Pharmaceuticals Limited

11.7.1 Intas Pharmaceuticals Limited Company Detail

11.7.2 Intas Pharmaceuticals Limited Business Overview

11.7.3 Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Introduction

11.7.4 Intas Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.7.5 Intas Pharmaceuticals Limited Recent Development

11.8 Indivior

11.8.1 Indivior Company Detail

11.8.2 Indivior Business Overview

11.8.3 Indivior Cannabis Use Disorder Treatment Introduction

11.8.4 Indivior Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.8.5 Indivior Recent Development

11.9 Mallinckrodt

11.9.1 Mallinckrodt Company Detail

11.9.2 Mallinckrodt Business Overview

11.9.3 Mallinckrodt Cannabis Use Disorder Treatment Introduction

11.9.4 Mallinckrodt Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.9.5 Mallinckrodt Recent Development

11.10 Noramco

11.10.1 Noramco Company Detail

11.10.2 Noramco Business Overview

11.10.3 Noramco Cannabis Use Disorder Treatment Introduction

11.10.4 Noramco Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.10.5 Noramco Recent Development

11.11 Orexo AB

11.11.1 Orexo AB Company Detail

11.11.2 Orexo AB Business Overview

11.11.3 Orexo AB Cannabis Use Disorder Treatment Introduction

11.11.4 Orexo AB Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.11.5 Orexo AB Recent Development

11.12 Purdue Pharma

11.12.1 Purdue Pharma Company Detail

11.12.2 Purdue Pharma Business Overview

11.12.3 Purdue Pharma Cannabis Use Disorder Treatment Introduction

11.12.4 Purdue Pharma Revenue in Cannabis Use Disorder Treatment Business (2019-2024)

11.12.5 Purdue Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Dr. Reddy’s Laboratories

Glenmark Pharmaceuticals Limited

Intas Pharmaceuticals Limited

List of Tables

Table 1. Global Cannabis Use Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Tobacco/Nicotine and Vaping

Table 3. Key Players of Alcohol

Table 4. Key Players of Marijuana

Table 5. Key Players of Synthetic Cannabinoids

Table 6. Key Players of Others

Table 7. Global Cannabis Use Disorder Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Cannabis Use Disorder Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Cannabis Use Disorder Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Cannabis Use Disorder Treatment Market Share by Region (2019-2024)

Table 11. Global Cannabis Use Disorder Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Cannabis Use Disorder Treatment Market Share by Region (2025-2030)

Table 13. Cannabis Use Disorder Treatment Market Trends

Table 14. Cannabis Use Disorder Treatment Market Drivers

Table 15. Cannabis Use Disorder Treatment Market Challenges

Table 16. Cannabis Use Disorder Treatment Market Restraints

Table 17. Global Cannabis Use Disorder Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Cannabis Use Disorder Treatment Market Share by Players (2019-2024)

Table 19. Global Top Cannabis Use Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Use Disorder Treatment as of 2023)

Table 20. Ranking of Global Top Cannabis Use Disorder Treatment Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Cannabis Use Disorder Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Cannabis Use Disorder Treatment Product Solution and Service

Table 24. Date of Enter into Cannabis Use Disorder Treatment Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Cannabis Use Disorder Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Cannabis Use Disorder Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Cannabis Use Disorder Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Cannabis Use Disorder Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Cannabis Use Disorder Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Cannabis Use Disorder Treatment Revenue Market Share by Application (2019-2024)

Table 32. Global Cannabis Use Disorder Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Cannabis Use Disorder Treatment Revenue Market Share by Application (2025-2030)

Table 34. North America Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Cannabis Use Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Cannabis Use Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Cannabis Use Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Cannabis Use Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Cannabis Use Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Cannabis Use Disorder Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Cannabis Use Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Cannabis Use Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Cannabis Use Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Cannabis Use Disorder Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 49. AbbVie Company Detail

Table 50. AbbVie Business Overview

Table 51. AbbVie Cannabis Use Disorder Treatment Product

Table 52. AbbVie Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 53. AbbVie Recent Development

Table 54. Alkermes Company Detail

Table 55. Alkermes Business Overview

Table 56. Alkermes Cannabis Use Disorder Treatment Product

Table 57. Alkermes Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 58. Alkermes Recent Development

Table 59. BioCorRx Company Detail

Table 60. BioCorRx Business Overview

Table 61. BioCorRx Cannabis Use Disorder Treatment Product

Table 62. BioCorRx Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 63. BioCorRx Recent Development

Table 64. Cipla Limited Company Detail

Table 65. Cipla Limited Business Overview

Table 66. Cipla Limited Cannabis Use Disorder Treatment Product

Table 67. Cipla Limited Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 68. Cipla Limited Recent Development

Table 69. Dr. Reddy’s Laboratories Company Detail

Table 70. Dr. Reddy’s Laboratories Business Overview

Table 71. Dr. Reddy’s Laboratories Cannabis Use Disorder Treatment Product

Table 72. Dr. Reddy’s Laboratories Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 73. Dr. Reddy’s Laboratories Recent Development

Table 74. Glenmark Pharmaceuticals Limited Company Detail

Table 75. Glenmark Pharmaceuticals Limited Business Overview

Table 76. Glenmark Pharmaceuticals Limited Cannabis Use Disorder Treatment Product

Table 77. Glenmark Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 78. Glenmark Pharmaceuticals Limited Recent Development

Table 79. Intas Pharmaceuticals Limited Company Detail

Table 80. Intas Pharmaceuticals Limited Business Overview

Table 81. Intas Pharmaceuticals Limited Cannabis Use Disorder Treatment Product

Table 82. Intas Pharmaceuticals Limited Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 83. Intas Pharmaceuticals Limited Recent Development

Table 84. Indivior Company Detail

Table 85. Indivior Business Overview

Table 86. Indivior Cannabis Use Disorder Treatment Product

Table 87. Indivior Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 88. Indivior Recent Development

Table 89. Mallinckrodt Company Detail

Table 90. Mallinckrodt Business Overview

Table 91. Mallinckrodt Cannabis Use Disorder Treatment Product

Table 92. Mallinckrodt Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 93. Mallinckrodt Recent Development

Table 94. Noramco Company Detail

Table 95. Noramco Business Overview

Table 96. Noramco Cannabis Use Disorder Treatment Product

Table 97. Noramco Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 98. Noramco Recent Development

Table 99. Orexo AB Company Detail

Table 100. Orexo AB Business Overview

Table 101. Orexo AB Cannabis Use Disorder Treatment Product

Table 102. Orexo AB Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 103. Orexo AB Recent Development

Table 104. Purdue Pharma Company Detail

Table 105. Purdue Pharma Business Overview

Table 106. Purdue Pharma Cannabis Use Disorder Treatment Product

Table 107. Purdue Pharma Revenue in Cannabis Use Disorder Treatment Business (2019-2024) & (US$ Million)

Table 108. Purdue Pharma Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cannabis Use Disorder Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cannabis Use Disorder Treatment Market Share by Type: 2023 VS 2030

Figure 3. Tobacco/Nicotine and Vaping Features

Figure 4. Alcohol Features

Figure 5. Marijuana Features

Figure 6. Synthetic Cannabinoids Features

Figure 7. Others Features

Figure 8. Global Cannabis Use Disorder Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Cannabis Use Disorder Treatment Market Share by Application: 2023 VS 2030

Figure 10. Hospitals and Clinics Case Studies

Figure 11. Rehabilitation Centers Case Studies

Figure 12. Others Case Studies

Figure 13. Cannabis Use Disorder Treatment Report Years Considered

Figure 14. Global Cannabis Use Disorder Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Cannabis Use Disorder Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Cannabis Use Disorder Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global Cannabis Use Disorder Treatment Market Share by Players in 2023

Figure 18. Global Top Cannabis Use Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Use Disorder Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Cannabis Use Disorder Treatment Revenue in 2023

Figure 20. North America Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Cannabis Use Disorder Treatment Market Share by Country (2019-2030)

Figure 22. United States Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Cannabis Use Disorder Treatment Market Share by Country (2019-2030)

Figure 26. Germany Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Cannabis Use Disorder Treatment Market Share by Region (2019-2030)

Figure 34. China Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Cannabis Use Disorder Treatment Market Share by Country (2019-2030)

Figure 42. Mexico Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Cannabis Use Disorder Treatment Market Share by Country (2019-2030)

Figure 46. Turkey Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Cannabis Use Disorder Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. AbbVie Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 49. Alkermes Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 50. BioCorRx Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 51. Cipla Limited Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 52. Dr. Reddy’s Laboratories Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 53. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 54. Intas Pharmaceuticals Limited Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 55. Indivior Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 56. Mallinckrodt Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 57. Noramco Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 58. Orexo AB Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 59. Purdue Pharma Revenue Growth Rate in Cannabis Use Disorder Treatment Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions